Correlation between melasma severity and quality of life using mMASI and MELASQoL: A hospital-based cross-sectional study
Our Dermatology Online · 01.10.2026 · 4 (17)
DOI: 10.7241/ourd.20264.5 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Our Dermatology Online, online erschienen am 01.10.2026. Verfasst von Tejaswini Mukundraj und 7 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Melasma is a chronic acquired disorder of pigmentation that primarily involves the facial skin and is commonly associated with significant psychosocial burden.Because of its conspicuous facial involvement, melasma may markedly affect quality of life, and this effect does not always correspond to objective clinical severity.
Objectives
To evaluate the impact of melasma on quality of life using the Melasma Quality of Life (MELASQoL) questionnaire and to assess its correlation with disease severity measured by the modified Melasma Area and Severity Index (mMASI). Material and Methods:This hospital-based cross-sectional study included patients with clinically diagnosed melasma attending a tertiary care dermatology center.Disease severity was assessed using the modified Melasma Area and Severity Index (mMASI), while quality of life impairment was evaluated using the Melasma Quality of Life (MELASQoL) questionnaire.Appropriate descriptive and inferential statistical methods were employed to analyze the relationship between clinical severity and quality-of-life scores.
Results
The study population showed female predominance (74%), with most patients aged 31-40 years.A statistically significant moderate positive correlation was noted between mMASI scores and MELASQoL scores (r = 0.480, p < 0.001).Mean MELASQoL scores increased significantly with disease severity (low: 48.12 ± 11.12; moderate: 56.77 ± 6.27; high: 62.00 ± 2.83; p < 0.001).A majority of patients (57%) experienced severe quality-of-life impairment.Among evaluated variables, only mMASI severity and educational status showed significant association with MELASQoL severity categories.
Conclusion
Melasma severity shows a significant association with quality-of-life impairment; however, the moderate strength of correlation suggests that factors beyond objective clinical severity contribute substantially to patient-perceived burden.Routine evaluation of quality of life, along with clinical severity assessment, is essential for comprehensive and patient-centered management of melasma.
Zitieren
APA
Mukundraj, T., Kudligi, C., Shetty, A., Ahmad, U. H., Kumar, M. R., Chavan, A. F., Maniparambil, M. M., & Chandra, C. S. G. (2026). Correlation between melasma severity and quality of life using mMASI and MELASQoL: A hospital-based cross-sectional study. Our Dermatology Online, 4(17). https://doi.org/10.7241/ourd.20264.5
Vancouver
Mukundraj T, Kudligi C, Shetty A, Ahmad UH, Kumar MR, Chavan AF, et al. Correlation between melasma severity and quality of life using mMASI and MELASQoL: A hospital-based cross-sectional study. Our Dermatology Online. 2026;4(17). doi:10.7241/ourd.20264.5
BibTeX
@article{Mukundraj2026,
author = {Mukundraj, Tejaswini and Kudligi, Chandramohan and Shetty, Ashmika and Ahmad, Uzma Hassan and Kumar, Meghana Ravi and Chavan, Arpita Fakirappa and Maniparambil, Mahima Master and Chandra, Chaithra Shree Ganesh},
title = {Correlation between melasma severity and quality of life using mMASI and MELASQoL: A hospital-based cross-sectional study},
journal = {Our Dermatology Online},
year = {2026},
volume = {4},
number = {17},
doi = {10.7241/ourd.20264.5}
}
EUVIMED